Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 12,285 | Dovepress* | 11,516+ | 1,258 | 12,774 | |
| PubMed Central* | 769 | 243 | 1,012 | ||
| Totals | 12,285 | 1,501 | 13,786 | ||
| *Since 16 November 2018 | |||||
View citations on PubMed Central and Google Scholar